11 January 2022 in Akademik Gastroenteroloji Dergisi
Background and Aims: Hepatitis A virus is a cause of acute viral hepatitis that infects millions of people worldwide each year and maintains its prominence in both adults and in childhood. The aim of this study was to determine the hepatitis A seroprevalence in different age groups in Çorum which is the reference center for northern part of central Anatolia and to make recommendations for hepatitis A vaccine according to age groups. Materials and Methods: This retrospective study was conducted between January 2017 and January 2020. Patients tested for anti-hepatitis A virus for any reasons were enrolled from the data of all patients admitted to our hospital which is the reference center of the region. Serum samples were analyzed by ELISA. S/CO values of ≥ 1.00 were considered positive for anti-hepatitis A virus immunoglobulin G and immunoglobulin M, respectively; results below this value were considered negative. Anti hepatitis A virus immunoglobulin G and anti-hepatitis A virus immunoglobulin M results of patients were analyzed according to age groups. Results: A total of 18817 anti-hepatitis A virus immunoglobulin G and immunoglobulin M assays were screened from the computerized database. 4244 assays were excluded for repeated tests from the same patients and inconclusive data. The study included 4115 patients with anti-hepatitis A virus immunoglobulin M and 10458 patients with anti-hepatitis A virus immunoglobulin G. Total anti-hepatitis A virus immunoglobulin G and M positivities were 84.4% and 0.7%. Anti-hepatitis A virus immunoglobulin G prevalence was – 85.8% and 83%, and anti-hepatitis A virus immunoglobulin M positivity was – 0.98% and 0.38% in men and women. There was a significant difference in the prevalence of hepatitis A virus immunoglobulin G and immunoglobulin M according to age groups in Çorum (p < 0.001, p = 0.035). Anti-hepatitis A virus immunoglobulin G seronegativity for 11 - 20 years of age was 28.4% and for 21 - 30 years of age was 24.2%. Conclusion: This study suggests that 11 - 20 and 21 - 30 years of age groups may be in the highest risk group for hepatitis A virus infection with possible complications increasing with age, and this patient group constitutes the target population for vaccination.
3 October 2023 in Journal Français d'Ophtalmologie
26 September 2024 in Infectious Diseases and Clinical Microbiology
In 75-85% of cases of acute hepatitis C infection, the disease becomes chronic and carries a risk of developing liver failure and hepatocellular cancer. In its global hepatitis report published in 2017, the World Health Organization (WHO) reported that 71.1 (95% uncertainty interval [UI]: 62.1-79.0 million) million people were chronically infected with the hepatitis C virus
20 January 2023 in Journal of Ankara University Faculty of Medicine
3 October 2024 in Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi
Aim: The threat of antimicrobial resistance has been identified as one of the major challenges in the management of complicated intra-abdominal infections(cIAIs). In this study, we aimed to describe the clinical, microbiological and resistance profiles of complicated intra-abdominal infections and to assess the risk factors related to resistance and mortality. Material and Method: Seventy-nine patients undergoing surgery or interventional drainage for cIAIs with a positive microbiological culture were documented. Results: Among these patients 79,7% were affected by health care associated IAIs while remaining 20,3% cases were identified as cIAI in the community. In 79 cases, 143 microorganisms were isolated and the leading microorganism was E.coli (34.9%) followed by Enterococcus spp. (17.4%). Among Enterobacteriaceae (n:96), 53.6% of the strains had ESBL and 36.8% were Multi Drug Resistant (MDR) bacteria. The overall mortality rate was 22.8%. According to univariate analysis, the use of broad spectrum antibiotics between initial intervention and re-operation was a significant risk factor for presence of ESBL. By multivariate analysis of the data; isolation of MDR bacteria, Enterococcus spp as an etiologic agent and presence of chronic obstructive pulmonary disease were statistically significant indicators for mortality. Discussion: These data indicate that local community and nosocomial resistance patterns should guide empiric antimicrobial therapy. Conclusion: To have the efficient data for resistance patterns, culture of the materials should not be neglected in either hospital or community acquired IAIs.Due to the increase in the prevalence of ESBL positive and MDR bacteria, demonstration of the epidemiological data in populations and each hospital is crucially important for accurate selection of initial empirical antibiotherapy
22 May 2023 in Journal of Pulmonology and Intensive Care
Acute mediastinitis is still among the major causes of high mortality despite advances in antibiotic therapies, intensive care support, and novel diagnostic techniques. Mediastinitis may develop due to esophageal perforation, by a downward spread of neck infection, or after cardiothoracic surgery. While computed tomography is the most preferred imaging technique in diagnosis, broad-spectrum antibiotic therapy and surgical debridement are the mainstay of the treatment. It is essential to combine multiple interventions, such as appropriate antimicrobial prophylaxis, minimization of contamination, elimination of preoperative nasal S. aureus carriage, and the adoption of relevant surgical techniques, to prevent particularly postoperative mediastinitis.